Anti-BCL7A aptamer SELEX Service(Cat#: CTApt-1921)

Name: Anti-BCL7A aptamer SELEX Service
SKU: CTApt-1921
Rating: 5 (1 reviews)

This is an aptamer development services to screening aptamers binds to the BCL7A with an affinity of 1nM~1μM.

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

Specifications

Target Category	Protein
Target	BCL7A
Alternative Names	BAF Chromatin Remodeling Complex Subunit BCL7A; B-Cell CLL/Lymphoma 7 Protein Family Member A; BCL7A, BAF Complex Component; BCL Tumor Suppressor 7A; B-Cell CLL/Lymphoma 7A; B-Cell CLL/Lymphoma-7; BCL7A; BCL7
Gene ID	605
UniProt ID	Q4VC05
Target Overview	This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
Chemical Modification	N/A
Type	DNA
Length	20-80 nt
Affinity (Kd)	1nM~1μM
Binding Conditions/Buffer	PBS; buffer system with Serum; other